Glucocorticoids, 11β-hydroxysteroid dehydrogenase type 1, and visceral obesity

被引：5
|
作者：
Paulmyer-Lacroix, O
Boullu-Ciocca, S
Oliver, C
Dutour, A
Grino, M
机构：
[1] Univ Mediterranee, Inst Jean Rochei, UFR Med Secteur Nord, Lab Interact Fonctionnelles, F-13916 Marseille 20, France
[2] Hop Nord Marseille, Serv Endocrinol Malad Metab & Nutr, F-13015 Marseille, France
来源：
M S-MEDECINE SCIENCES | 2003年 / 19卷 / 04期
关键词：
D O I：
10.1051/medsci/2003194473
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Glucocorticoids are implicated as a pathophysiological mediator of obesity and its accompanying metabolic and cardiovascular complications. Obese patients exhibit normal circulating cortisol levels, related to increased glucocorticoid production and degradation. However, it has been demonstrated that local production of active cortisol from inactive cortisone driven by 11beta-hydroxysteroid dehydrogenase type 1 is exaggerated in adipose tissue of obese subjects. Such local hypercortisolism may be responsible for increased adipocyte differentiation and enhanced secretion of free fatty acids and other substances involved in the metabolic and cardiovascular complications observed in obesity.
引用
收藏
页码：473 / 476
页数：4
相关论文
共 50 条
  • [41] The role and regulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
    Stimson, Roland H.
    Walker, Brian R.
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2013, 15 (02) : 37 - 48
  • [42] Adipose tissue expression of 11β-hydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity
    Espindola-Antunes, Daniela
    Kater, Claudio E.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (08) : 1397 - 1403
  • [43] Inhibition of 11β-hydroxysteroid dehydrogenase type 1 ameliorates obesity-related insulin resistance
    Shao, Shiying
    Zhang, Xiaojie
    Zhang, Muxun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 478 (01) : 474 - 480
  • [44] Adipose tissue 11β-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome
    Mariniello, Barbara
    Ronconi, Vanessa
    Rilli, Silvia
    Bernante, Paolo
    Boscaro, Marco
    Mantero, Franco
    Giacchetti, Gilberta
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 155 (03) : 435 - 441
  • [45] 11β-hydroxysteroid dehydrogenase activity in hypothalamic obesity
    Tiosano, D
    Eisentein, I
    Militianu, D
    Chrousos, GP
    Hochberg, Z
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01): : 379 - 384
  • [46] 11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesity
    Hughes, Katherine A.
    Webster, Scott P.
    Walker, Brian R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (04) : 481 - 496
  • [47] Generation of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1 within intact mouse aorta is not enhanced by proinflammatory cytokines
    Dover, AR
    Ogston, E
    Hadoke, PWF
    Newby, DE
    Walker, BR
    HYPERTENSION, 2004, 44 (04) : 566 - 566
  • [48] THE DETRIMENTAL SIDE EFFECTS OF THERAPEUTIC GLUCOCORTICOIDS ON BONE ARE MEDIATED BY THEIR LOCAL REACTIVATION BY 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1
    Fenton, Chloe
    Doig, Craig
    Raza, Karim
    Coopers, Mark
    Lavery, Gareth
    Hardy, Rowan
    RHEUMATOLOGY, 2018, 57
  • [49] Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue
    Seckl, JR
    Morton, NM
    Chapman, KE
    Walker, BR
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 59, 2004, 59 : 359 - 393
  • [50] Cortisol metabolism and visceral obesity:: Role of 11β-hydroxysteroid dehydrogenase type I enzyme and reduced co-factor NADPH
    Agarwal, AK
    ENDOCRINE RESEARCH, 2003, 29 (04) : 411 - 418
12345